Billionaire Mark Cuban launched CostPlus Drugs, disrupting the prescription drug industry in 2022. President Trump announced TrumpRx, a government-run platform set to go live in early 2026. Both promise lower prices by cutting out the middleman. CostPlus Drugs adds a 15% markup, $5 pharmacy charge, and shipping fee, offering generics and some brand-name prescriptions. TrumpRx directs users to manufacturers’ websites for brand-name prescriptions at reduced prices. Pfizer is the only company onboard so far, limiting drug selection. CostPlus Drugs accepts insurance and offers generics at reduced prices, while TrumpRx does not accept insurance or offer generics.

Read more at Yahoo Finance: TrumpRx.Gov vs. Mark Cuban’s Cost Plus Drugs: Which Saves Retirees More?